Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001892459 | SCV002147584 | pathogenic | not provided | 2023-07-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1383249). This variant has not been reported in the literature in individuals affected with EYS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln494*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). |
Baylor Genetics | RCV004571519 | SCV005060469 | likely pathogenic | Retinitis pigmentosa 25 | 2024-03-06 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV004571519 | SCV005672755 | likely pathogenic | Retinitis pigmentosa 25 | 2024-04-10 | criteria provided, single submitter | clinical testing |